Head & Neck/Thyroid Cancers
News
Multimodal therapies almost double survival in anaplastic thyroid cancer
CHICAGO – One cancer center’s experience shows that a targeted, multidisciplinary approach makes a difference.
Conference Coverage
Toward Improving the Delivery of Oral Anticancer Drugs in the VA: Work IN PROGRESS
Conference Coverage
Evaluation of the Implementation of a 90-Minute Rituximab Infusion Protocol at the Richard L. Roudebush VA Medical Center
Conference Coverage
Improving Oral Chemotherapy Documentation Using QOPI Audit, Plan-Do-Study-Act Cycles, and the Electronic Medical Record
Conference Coverage
Radiation Therapy Treatment Breaks and Weight Changes in Head and Neck Cancer Patients in a Veterans Affairs Radiation Oncology Clinic
Conference Coverage
Benefits of Psychosocial Participation in a Head and Neck Cancer Tumor Board at the VA Palo Alto Health Care System: Two Case Examples
News
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapy
The most common immune-related adverse events warranting hospital admission were pneumonitis and colitis.
Clinical Topics & News
Prevalence of Cancer in Thyroid Nodules In the Veteran Population
Thyroid nodules are identified incidentally in 4% to 10% of the general population in the US.1,2...
Clinical Topics & News
VHA Practice Guideline Recommendations for Diffuse Gliomas
Although histology still plays a critical role in diagnosing diffuse gliomas, additional ancillary testing is an essential tool for VA pathology...
News
PET imaging at diagnosis improves oropharyngeal cancer outcomes
In patients with oropharyngeal cancer, initial staging with PET imaging was associated with better cancer-specific survival than staging with...
